Marvel Biosciences Announces Private Placement to Raise up to C$3M
Marvel Biosciences (OTCQB:MBCOF) is launching a non-brokered private placement offering between C$1.5 million and C$3 million through the issuance of 10 million to 20 million units at C$0.15 per unit. Funds will be used for clinical trial deposits, general expenses, and working capital.
